Some studies published the association between CCL2 and CCR2 gene polymorphisms and AMD pathogenesis [19,35,36] and identified complement cascade genes, cytokines, and chemokine signaling pathways, including CCL2, as potential novel moderators of AMD [37]. The gene discussed is CCL2; the disease is age-related macular degeneration.